Impacto Públicocivic observatory
Portuguêspt-PTEnglishcurrent languageEspañoles-ES

PUBLIC CONTRACT · 2022

Vários medicamentos

Contract value
€6,873.47
Signed on
18 May 2022
Procedure
Direct award, general (Ajuste Direto Regime Geral)

This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.

Record 9272585

PUBLISHED DESCRIPTION

41011622 - AQ Urgente medicamentos

Parties involved

Place of performance
Portugal, Setúbal, Setúbal
NUTS region
Not stated

WHO BID

Awardee and competitors

Companies that IMPIC lists as the awardee and as competitors in this procedure.

Awardee
Novo Nordisk, Com. Prod. Farmacêuti · Tax ID 501485210
Awardee
Bausch & Lomb, SA · Tax ID 980218764
Awardee
LABORATORIOS NORMON,SA · Tax ID 505654156
Awardee
GRUNENTHAL,SA · Tax ID 500101965
Awardee
TEVA PHARMA - PRODUTOS FARMACEUTICOS,LDA · Tax ID 507045491
Awardee
JANSSEN CILAG FARMACEUTICA, LDA. · Tax ID 500189412

Values and timeline

Contract price
€6,873.47
Procedure base price
€6,873.47
Total effective price
Not reported on Portal BASE
Publication date
23 May 2022
Award date
18 May 2022
Signing date
18 May 2022
Performance period
12 days

The contract price is the value agreed in the contract, not the amount paid.

Procedure and framework

Contract type
Aquisição de bens móveis
Award criterion
Monofator
CPV code
33000000-0 - Equipamento médico, medicamentos e produtos para cuidados pessoais
Legal basis
Artigo 24.º, n.º 1, alínea c) do Código dos Contratos Públicos
Regime
Código dos Contratos Públicos ( DL 111-B/2017 )
Framework agreement
Not stated
Centralised procedure
No
Environmental criterion
No
Notice
Not stated
Procedure identifier
5926696

Compare with other contracts

Search the same body, supplier, place or type of service to understand the context of the published index.

← Back to contracts